Male breast cancer (MBC) is a rare disease, accounting for about 1% of all breast cancer cases and less than 0.5% of all male cancers worldwide12. Although uncommon, its incidence has been slowly increasing over recent decades, with approximately 2,650 new cases diagnosed annually in the United States13. Early detection is critical, as survival rates vary widely by stage, with early-stage disease showing a 5-year survival rate near 95%, while metastatic disease survival drops to 20-30%45.
Types of Male Breast Cancer
Male breast cancer originates primarily in the breast ducts or lobules, though the male breast contains fewer lobules than the female breast62. The most common histologic subtype is invasive ductal carcinoma (IDC), which accounts for approximately 90% of male breast cancer cases732. IDC begins in the milk ducts, which in men are smaller and centrally located, and can invade surrounding tissues including the nipple6.
Other types of male breast cancer include:
- Ductal carcinoma in situ (DCIS): A non-invasive form confined to the ducts, considered a precursor lesion that may progress to invasive carcinoma68.
- Invasive lobular carcinoma (ILC): Rare in men due to the scarcity of lobules, but more common in women; it originates in the lobules and can be in situ or invasive28.
- Paget disease of the nipple: A rare form involving the nipple and areola, comprising about 5% of male breast cancer cases, characterized by skin changes such as scaling and redness8.
Male Breast Cancer Symptoms and Signs
The clinical presentation of male breast cancer varies depending on tumor type and stage2. The most common initial symptom is a painless lump or thickening in one breast, often located behind the nipple69. Other signs and symptoms include:
- Nipple inversion or retraction810.
- Nipple tenderness or pain8.
- Skin changes such as redness, scaling, dimpling, or puckering resembling orange peel skin21110.
- Nipple discharge, which may be clear, serous, or bloody610.
- Enlarged axillary (underarm) lymph nodes, often indicating metastatic spread8.
Because men are not routinely screened, symptoms are often the first indication of disease, underscoring the importance of prompt medical evaluation for any breast changes1213.
Causes and Risk Factors
Male breast cancer arises from uncontrolled growth of abnormal cells in the breast ducts or lobules2. The exact causes remain incompletely understood, but several factors contribute to increased risk14.
Risk Factors
- Advanced age: Most cases occur in men over 60, with risk increasing with age1516.
- Genetic mutations: BRCA2 mutations are strongly associated with male breast cancer risk, more so than BRCA11517.
- Family history: Having close relatives with breast cancer elevates risk1710.
- Hormonal imbalances: Conditions causing elevated estrogen levels, such as Klinefelter syndrome, liver cirrhosis, or estrogen therapy for prostate cancer, increase risk151410.
- Prior chest radiation: Exposure to radiation, especially in childhood or for other cancers, is a known risk factor14.
- Obesity: Linked to higher estrogen levels and increased incidence of male breast cancer1819.
- Testicular conditions: Including orchitis (inflamed testicles), undescended testicles, or orchiectomy (removal of testicles)10.
Other less common genetic mutations and environmental exposures may also play roles14.
Diagnosis and Staging
Diagnosis begins with a thorough clinical breast examination to detect lumps, skin changes, or nipple abnormalities620. Imaging studies such as mammography and ultrasound are used to identify suspicious lesions and assess lymph node involvement68. Definitive diagnosis requires histopathological examination of biopsy specimens6.
Cancer staging follows the TNM system, considering tumor size, nodal involvement, and metastasis620. Staging is crucial for treatment planning and prognosis.
Stages of Breast Cancer
| Stage | Description | Tumor Size & Spread | Survival Rate (5-year)45 |
|---|---|---|---|
| 0 | Abnormal cells confined to ducts (DCIS), no invasion | No invasive tumor | High, often curable |
| I | Early invasive cancer, tumor ≤ 2 cm, no lymph node involvement | Tumor ≤ 2 cm, no nodal spread | 75-95% |
| II | Larger tumor (2-5 cm) or spread to a few axillary lymph nodes | Tumor 2-5 cm, limited nodal involvement | Moderate |
| III | Locally advanced cancer with extensive lymph node involvement or chest wall/skin invasion | Larger tumor, multiple lymph nodes, possible chest wall involvement | Lower |
| IV | Metastatic cancer spread to distant organs such as bone, liver, lung, or brain | Any tumor size with distant metastases | 20-30% |
| Sources:45 | |||
Metastatic sites commonly include bone, liver, lungs, and brain, leading to symptoms such as bone pain, jaundice, respiratory issues, and neurological deficits68.
Male Breast Cancer Treatment Options
Treatment depends on cancer type, stage, and hormone receptor status38. A multidisciplinary approach often combines surgery, radiation, chemotherapy, hormone therapy, and targeted therapy.
Surgery
Surgical removal of the tumor is the primary treatment for localized male breast cancer68. Mastectomy (removal of the entire breast) is the most common procedure due to the small size of male breast tissue6. Breast-conserving surgery (lumpectomy) is less common but may be an option in select cases6.
Lymph node removal (axillary lymph node dissection) is performed if nodal metastasis is suspected or confirmed8.
Radiation Therapy
Postoperative radiotherapy is used to destroy residual cancer cells and reduce recurrence risk, especially in advanced or node-positive disease68. Radiation targets the chest wall and regional lymph nodes.
Chemotherapy
Systemic chemotherapy aims to eliminate residual disease and reduce the risk of metastasis8. It may be given before surgery (neoadjuvant) to shrink tumors or after surgery (adjuvant) to target microscopic disease6.
Hormone Therapy
Most male breast cancers express hormone receptors (estrogen and/or progesterone receptors)17. Hormone therapy blocks estrogen action or lowers estrogen levels, effectively controlling hormone receptor-positive tumors. Tamoxifen is the most commonly used agent17.
Targeted Therapy
Targeted treatments interfere with specific molecular pathways driving cancer growth. For example, HER2-positive cancers may respond to anti-HER2 therapies, while BRCA mutation carriers may benefit from PARP inhibitors2117.
Breast Cancer Screening for Men
Routine breast cancer screening is not recommended for average-risk men due to the low incidence of male breast cancer810. However, men at high risk, such as those with BRCA mutations or a strong family history, should consider regular clinical breast exams and possibly imaging1710.
Any palpable breast mass or nipple changes in men warrant prompt medical evaluation, regardless of risk status613.
“A lot of the times, it's either dismissed by your medical team or the patient themselves as, 'Oh, what is this? It's probably nothing, or a pulled muscle,' but usually it'll persist. It won't go away. And then over time, it will start to get larger.”
— Dr. Emil Fernando, Allegheny Health Network13
Related Health Conditions
Several conditions are related to or may mimic male breast cancer:
- Gynecomastia: Benign enlargement of male breast tissue, often due to hormonal imbalances, medications, or liver disease22.
- Testicular disorders: Conditions affecting testicular function can alter hormone levels, increasing breast cancer risk10.
- Klinefelter syndrome: A genetic disorder causing an extra X chromosome, leading to higher estrogen levels and increased risk15.
- Liver cirrhosis: Alters hormone metabolism, raising estrogen and breast cancer risk14.
Differentiating benign conditions from malignancy is essential for appropriate management6.
Living With Male Breast Cancer
Living with male breast cancer involves managing physical symptoms, treatment side effects, and psychosocial challenges. Metastatic disease can cause complications such as bone pain, fractures, jaundice, respiratory symptoms, and neurological deficits depending on the sites of spread68.
Emotional support and self-care practices improve quality of life during and after treatment23. Support groups and advocacy organizations provide valuable resources for patients and families23.
“I think it's really amazing. It's really inspiring to find that inner strength and motivation to say, 'I'm going to still fight this and beat this.'”
— Dr. Emil Fernando, Allegheny Health Network13
Frequently Asked Questions
Q: How common is male breast cancer?
A: Male breast cancer is rare, accounting for about 1% of all breast cancers and less than 0.5% of male cancers. The lifetime risk for men is approximately 1 in 700 to 1 in 1,00011624.
Q: What are the early signs of male breast cancer?
A: The most common early sign is a painless lump or thickening behind the nipple. Other symptoms include nipple inversion, discharge, skin changes, and enlarged lymph nodes6910.
Q: Should men get screened for breast cancer?
A: Routine screening is not recommended for average-risk men. High-risk men, such as those with BRCA mutations or family history, should discuss screening options with their healthcare provider1710.
Q: What is the prognosis for male breast cancer?
A: Prognosis depends on the stage at diagnosis. Early-stage disease has a 5-year survival rate of 75-95%, while metastatic disease survival is much lower, around 20-30%45.
Q: What treatments are available for male breast cancer?
A: Treatment options include surgery (usually mastectomy), radiation, chemotherapy, hormone therapy, and targeted therapy, tailored to tumor type and stage38.
